Allergan Investors Sue Board Over Tax Tab For Exec Pay

Law360, New York (November 23, 2011, 8:04 PM EST) -- Allergan Inc.'s board of directors was hit Monday with a shareholder derivative suit alleging it issued a misleading statement asking shareholders to approve a defective executive compensation plan that cost the pharmaceutical company millions in tax benefits.

In a complaint filed in Delaware federal court, the New Jersey Building Laborers Pension Fund said Allergan's March 8 proxy statement requesting shareholder approval of the 2011 incentive plan claimed the plan would be tax-deductible if the stockholders signed off on an amendment to it.

But even with approval,...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

New Jersey Building Laborers Pension Fund v. Ball et al


Case Number

1:11-cv-01153

Court

Delaware

Nature of Suit

Stockholders Suits

Judge

Leonard P. Stark

Date Filed

November 20, 2011

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.